1. Pink Sheet
  2. >>Regions
  3. >>Europe

UK QPPVs Fear Brexit Could Seriously Threaten Their Role In Pharmacovigilance

 
• By Vibha Sharma
  
Generate a summary of this article
Listen to this article
Beta

UK based QPPVs are worried about the direct and tangible impact of Brexit on their current jobs, fearing that the QPPV role may either completely vanish from the UK or have its authority undermined.

A group of UK-based qualified persons for pharmacovigilance (QPPVs), who are concerned about their future role in the EU pharmacovigilance system following the Brexit vote, have welcomed a recent report by the UK Parliament's "Brexit Committee" on the need for clarity as soon as possible, and certainly by the time the UK leaves the European Union, about the government's preferred option for future participation in EU regulatory bodies.

A QPPV fulfils a number of pharmacovigilance-related obligations for a company or a marketing authorization holder, and the EU pharmacovigilance...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By Saba Afreen

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     
    • By Anabel Costa-Ferreira and Ian Schofield

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography